{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:41:01Z","timestamp":1790959261535,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T00:00:00Z","timestamp":1438128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0134408","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T18:08:41Z","timestamp":1438193321000},"page":"e0134408","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population"],"prefix":"10.1371","volume":"10","author":[{"given":"Edward S. Y.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Shekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire H. T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis Z.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk-Yean","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toomas","family":"Silla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarabelle","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Davila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathijs","family":"Voorhoeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aye Aye","family":"Thike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gay Hui","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Sim","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puay Hoon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Han","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann S. G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,29]]},"reference":[{"key":"ref1","unstructured":"National Comprehensive Cancer Network I (2014) The NCCN Guidelines Genetic\/Familial High-Risk Assessment: Breast and Ovarian. (Version 2.2014). Retrieved 09\/23\/14."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/jmedgenet-2011-100006","article-title":"Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer","volume":"48","author":"DG Evans","year":"2011","journal-title":"J Med Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10549-011-1433-2","article-title":"Relative contributions of BRCA1 and BRCA2 mutations to &quot;triple-negative&quot; breast cancer in Ashkenazi Women","volume":"129","author":"E Comen","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e38361","DOI":"10.1371\/journal.pone.0038361","article-title":"BRCA2 mutations and triple-negative breast cancer","volume":"7","author":"P Meyer","year":"2012","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10549-012-2021-9","article-title":"Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study","volume":"134","author":"F Fostira","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ejhg.2012.270","article-title":"Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes","volume":"21","author":"L Feliubadalo","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jmoldx.2012.06.003","article-title":"Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform","volume":"14","author":"M Chan","year":"2012","journal-title":"J Mol Diagn"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-012-2057-x","article-title":"Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer","volume":"134","author":"K Snape","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment","volume":"32","author":"AW Kurian","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref10","article-title":"Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes","author":"L Castera","year":"2014","journal-title":"Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.1073\/pnas.1007983107","article-title":"Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing","volume":"107","author":"T Walsh","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/1097-0142(20000815)89:4<811::AID-CNCR13>3.0.CO;2-R","article-title":"Novel germline BRCA1 mutations detected in women in singapore who developed breast carcinoma before the age of 36 years","volume":"89","author":"GH Ho","year":"2000","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1158\/1055-9965.EPI-07-0403","article-title":"BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a comprehensive strategy","volume":"16","author":"P Ang","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jcp.2010.085423","article-title":"HER2\/neu revisited: quality and interpretive issues","volume":"64","author":"SS Ahmed","year":"2011","journal-title":"J Clin Pathol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1186\/bcr2857","article-title":"Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy","volume":"13","author":"YH Teng","year":"2011","journal-title":"Breast Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2559.2012.04255.x","article-title":"Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer","volume":"61","author":"J Iqbal","year":"2012","journal-title":"Histopathology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"A McKenna","year":"2010","journal-title":"Genome Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"i318","DOI":"10.1093\/bioinformatics\/btq214","article-title":"A statistical method for the detection of variants from next-generation resequencing of DNA pools","volume":"26","author":"V Bansal","year":"2010","journal-title":"Bioinformatics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1098-1004(1999)13:3<256::AID-HUMU12>3.0.CO;2-M","article-title":"Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6\/16 flemish families with breast and\/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online","volume":"13","author":"K Claes","year":"1999","journal-title":"Hum Mutat"},{"key":"ref20","first-page":"1059","article-title":"Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families","volume":"60","author":"E Levy-Lahad","year":"1997","journal-title":"Am J Hum Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","article-title":"Founder BRCA1\/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control","volume":"1","author":"R Janavicius","year":"2010","journal-title":"Epma J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/1471-2164-15-516","article-title":"Evaluation and optimisation of indel detection workflows for ion torrent sequencing of the BRCA1 and BRCA2 genes","volume":"15","author":"ZX Yeo","year":"2014","journal-title":"BMC Genomics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10549-014-2894-x","article-title":"Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history","volume":"144","author":"PC Kang","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"E Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y","article-title":"Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women","volume":"80","author":"SE Karp","year":"1997","journal-title":"Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<310::AID-CNCR15>3.0.CO;2-W","article-title":"Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes","volume":"83","author":"N Loman","year":"1998","journal-title":"Cancer"},{"key":"ref27","first-page":"471","article-title":"Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer","volume":"56","author":"F Eisinger","year":"1996","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.1998.16.5.1642","article-title":"BRCA-associated breast cancer in young women","volume":"16","author":"M Robson","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(97)07065-7","article-title":"Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1","volume":"351","author":"LC Verhoog","year":"1998","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","article-title":"Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer","volume":"26","author":"DP Atchley","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/1078-0432.CCR-03-1061","article-title":"Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type","volume":"10","author":"WD Foulkes","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/bcr3347","article-title":"Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer","volume":"14","author":"SY Phuah","year":"2012","journal-title":"Breast Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/BD-2010-0306","article-title":"BRCA1\/2 mutations and triple negative breast cancers","volume":"32","author":"BN Peshkin","year":"2010","journal-title":"Breast Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-011-1711-z","article-title":"Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations","volume":"130","author":"S Bayraktar","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10549-014-3006-7","article-title":"A multi-institutional study on the association between BRCA1\/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients","volume":"146","author":"MW Seong","year":"2014","journal-title":"Breast Cancer Res Treat"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0134408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:51:40Z","timestamp":1540029100000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0134408"}},"subtitle":[],"editor":[{"given":"Peiwen","family":"Fei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,29]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0134408","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,29]]}}}